What is Ezra?
Ezra is at the forefront of medical imaging innovation, leveraging artificial intelligence to offer a comprehensive, full-body cancer screening service. This service is designed to be fast, accurate, and accessible, aiming to establish early cancer detection as a standard component of annual health check-ups. By empowering individuals with crucial health insights, Ezra is dedicated to transforming preventative healthcare and enabling informed health decisions.
How much funding has Ezra raised?
Ezra has raised a total of $21.3M across 2 funding rounds:
Other Financing Round
$21M
Debt
$250K
Other Financing Round (2024): $21M with participation from Healthier Capital, FirstMark Capital, Seedcamp, and Gaingels
Debt (2024): $250K led by TD Bank Group
Key Investors in Ezra
FirstMark Capital
FirstMark Capital is a venture capital firm based in New York City, specializing in Information & Document Management. They focus on supporting early-stage companies with significant growth potential.
Seedcamp
Seedcamp is a prominent European venture capital firm that invests in and mentors early-stage startups. They are known for backing ambitious founders across various sectors, including technology and fintech.
Gaingels
Gaingels is a leading investment syndicate focused on supporting and representing the LGBTQ community and allies in venture capital. They invest in high-growth companies committed to building inclusive teams across diverse sectors.
What's next for Ezra?
The substantial enterprise-level capital infusion, including the recent strategic investment, positions Ezra for accelerated growth and market expansion. This backing is expected to fuel further development of its AI technology, enhance its service offerings, and broaden its geographical reach. Ezra's commitment to creating a new standard in preventative care, coupled with its focus on early cancer detection, suggests a strategic trajectory aimed at capturing a significant share of the evolving healthcare technology market.
See full Ezra company page
